OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
5
Results
Show all
Save search
Copy query
Show results for
Unknown
(5)
Publication Date
Release Date
2021
(2)
2024
(1)
2016
(1)
2015
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.
Not available
S-EPMC4872017
|
biostudies-literature
Cite
Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
Not available
S-EPMC8639672
|
biostudies-literature
Cite
Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
Not available
S-EPMC5535796
|
biostudies-literature
Cite
Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.
Not available
S-EPMC10839617
|
biostudies-literature
Cite
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report.
Not available
S-EPMC8944207
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets